Sonoma gets series B boost:
This article was originally published in Clinica
Executive Summary
Sonoma Orthopedic Products has received additional funding in an oversubscribed series B round, the North Bay Business Journal has reported. The Santa Rosa, California start-up, which designs minimally-invasive implants for bone repair, is operating in stealth mode and has not disclosed the amount raised, although it revealed that the lead investor in this new round was MedVenture Associates, of Emeryville, California. Existing shareholders EDF Ventures, Asset Management Company and the Halo Fund also participated in the financing. The company's products are expected to receive FDA approval this year.
You may also be interested in...
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.